Legend Biotech Corp logo

Legend Biotech Corp (LEGN)

$41.39

Legend Biotech Corp (LEGN) Share Price Forecast
Currently 27 wall-street analysts regularly analyze the financials of Legend Biotech Corp on a frequent basis to provide recommendations along with target share price. 27 analysts offering 12-month price forecasts for Legend Biotech Corp (LEGN) have a share price target of $83.14. This median of share price forecast represents a 100.87% upside from the latest price of $41.39 as on 08.11.24.

Legend Biotech Corp (LEGN) Price vs Consensus Price Target

Price
Target Price
As per the chart shown above, analysts believe that the Legend Biotech Corp (LEGN) share price will touch around $83.14 in next 12-months.
Legend Biotech Corp (LEGN) Share Price Forecast v/s Share Price Today
Below is a chart showing the percentage difference between Legend Biotech Corp's share price and its median forecast price. As on 08.11.24, the difference is -46.64%

Legend Biotech Corp (LEGN): Difference between Current Price & Median Forecasted Price

Difference in Percentage terms
Legend Biotech Corp (LEGN) Share Price : Analyst Recommendation
Based on 27 analysts tracking and researching Legend Biotech Corp (LEGN) share have buy recommendation on an average.

3M Ago1M AgoCurrent
Buy
13
14
16
Outperform
8
8
8
Hold
4
4
3
Underperform
0
0
0
Sell
0
0
0
Legend Biotech Corp (LEGN) Share Price Technical Analysis

50 Day Moving Average v/s Current Share Price

Moving Average
Price

200 Day Moving Average v/s Current Share Price

Moving Average
Price

FAQs

The latest share price target for Legend Biotech Corp (LEGN) is $83.14, offered by 27 analysts offering 12-month price forecasts.

Legend Biotech Corp (LEGN) has a maximum of 1.01 upside potential, based on 27 analysts offering 12-month price forecasts.

Based on 27 analysts tracking and researching Legend Biotech Corp (LEGN), 88.89% have a buy recommendation. Remaining 11.11% have either sell or hold recommendations.

The latest share price of Legend Biotech Corp (LEGN) is $41.39 as of 08/11/2024.

24 of total 27 analysts offering stock ratings for Legend Biotech Corp LEGN have recommended buy rating.